/guid/9202a8c04000641f80000000055ac5c4 rename
Summary
Lexatumumab (also known as ETR2-ST01) is an agonistic human monoclonal antibody against TRAIL-R2 ...
Content
Lexatumumab (also known as ETR2-ST01) is an agonistic human monoclonal antibody against TRAIL-R2 (DR5, APO-2) used in the treatment of cancer.
This drug was developed by Human Genome Sciences, Inc.
Created by:
Freebase Data Team
Jul 28, 2007
Last edited by:
Freebase Data Team
Jul 28, 2007
Recent Discussions about None
There is no discussion about this document.
Start the Discussion »